Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A PHASE III TRIAL EMPLOYING CONFORMAL PHOTONS WITH PROTON BOOST IN EARLY STAGE PROSTATE CANCER: CONVENTIONAL DOSE COMPARED TO HIGH DOSE IRRADIATION

NCT00002703 is registered in ClinicalTrials.gov with Proton Radiation Oncology Group as lead sponsor.

NCT NCT00002703
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00002703 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A PHASE III TRIAL EMPLOYING CONFORMAL PHOTONS WITH PROTON BOOST IN EARLY STAGE PROSTATE CANCER: CONVENTIONAL DOSE COMPARED TO HIGH DOSE IRRADIATION
Lead sponsor
Proton Radiation Oncology Group
Phase
Phase 3
Overall status
Completed
Start date
January 31, 1996
Completion date
September 30, 2005
Enrollment
390 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer